Vyome Holdings, Inc.

HIND Stock Healthcare Biotechnology
$2.17
+0.01 (+0.45%)
Price as of Sep 01, 2026 market close

Performance

1 Month
+0.2%
3 Months
-5.7%
YTD
-36.9%
1 Year
-76.4%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
81.2%
Largest decline max drawdown, since Aug 2025
-83.6%
Risk-adjusted return Sharpe ratio, 1-year
-1.37

Own HIND?

See how HIND contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.